ERG and prostate carcinoma: The gene fusion product transmembrane-protease-serine-2 (TMPRSS2)-ETS-related gene (ERG) as a result of chromosomal translocation is observed in 20 to 50% of prostate cancer patients with different ethnicities (13, 14).